Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis ; volume:14 ; number:1 ; day:22 ; month:3 ; year:2024 ; pages:1-8 ; date:12.2024
Blood cancer journal ; 14, Heft 1 (22.3.2024), 1-8, 12.2024
- Creator
-
Hoff, Fieke W.
Banerjee, Rahul
Khan, Adeel M.
McCaughan, Georgia
Wang, Bo
Wang, Xiaoliang
Roose, James
Anderson, Larry D.
Cowan, Andrew J.
Rajkumar, S. Vincent
Kaur, Gurbakhash
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-024-01034-6
- URN
-
urn:nbn:de:101:1-2405232118570.831017503869
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hoff, Fieke W.
- Banerjee, Rahul
- Khan, Adeel M.
- McCaughan, Georgia
- Wang, Bo
- Wang, Xiaoliang
- Roose, James
- Anderson, Larry D.
- Cowan, Andrew J.
- Rajkumar, S. Vincent
- Kaur, Gurbakhash
- SpringerLink (Online service)
Other Objects (12)
Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
Frequency and change mechanisms of psychotherapy among depressed patients: study protocol for a multicenter randomized trial comparing twice-weekly versus once-weekly sessions of CBT and IPT
Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis
Enhanced disulphide bond stability contributes to the once-weekly profile of insulin icodec
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
Cost-effectiveness of twice-weekly versus once-weekly sessions of cognitive–behavioural therapy and interpersonal psychotherapy for depression at 12 months after start of treatment : : randomised controlled trial
Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
Frequency and change mechanisms of psychotherapy among depressed patients: study protocol for a multicenter randomized trial comparing twice-weekly versus once-weekly sessions of CBT and IPT
Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis
Enhanced disulphide bond stability contributes to the once-weekly profile of insulin icodec
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
Cost-effectiveness of twice-weekly versus once-weekly sessions of cognitive–behavioural therapy and interpersonal psychotherapy for depression at 12 months after start of treatment : : randomised controlled trial
Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
Frequency and change mechanisms of psychotherapy among depressed patients: study protocol for a multicenter randomized trial comparing twice-weekly versus once-weekly sessions of CBT and IPT
Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis
Enhanced disulphide bond stability contributes to the once-weekly profile of insulin icodec
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
Cost-effectiveness of twice-weekly versus once-weekly sessions of cognitive–behavioural therapy and interpersonal psychotherapy for depression at 12 months after start of treatment : : randomised controlled trial